MedDataX Logo

Safety and Effectiveness of BOTOX® for Lateral Canthal Lines With or Without Simultaneous Glabellar Lines in Korea

NCT ID: NCT02248844

Last Updated: 2019-07-05

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

667 participants

Study Classification

OBSERVATIONAL

Study Start Date

2014-09-26

Study Completion Date

2017-08-14

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This is a postmarketing surveillance study in Korea to evaluate the safety and effectiveness of BOTOX® for lateral canthal lines (crow's feet lines) with or without simultaneous glabellar lines.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Safety and Efficacy Study of Botulinum Toxin Type A for the Treatment of Crow's Feet Lines and Frown Lines

NCT01224015

Facial Rhytides Crow's Feet Lines Glabellar Lines
COMPLETED PHASE3

BOTOX® in the Treatment of Crow's Feet Lines in Japan

NCT01797081

Lateral Canthus Rhytides Crow's Feet Lines
COMPLETED PHASE3

Safety and Efficacy of BOTOX® (Botulinum Toxin Type A) in Korea

NCT02043145

Hyperhidrosis Muscle Spasticity Glabellar Lines
COMPLETED

Safety and Efficacy Study of Botulinum Toxin Type A for the Treatment of Crow's Feet Lines

NCT01189747

Lateral Canthus Rhytides Crow's Feet Lines
COMPLETED PHASE3

Safety and Efficacy Study of Botulinum Toxin Type A for the Treatment of Crow's Feet Lines and Frown Lines

NCT01189760

Facial Rhytides Crow's Feet Lines Glabellar Lines
COMPLETED PHASE3

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Lateral Canthal Lines Crow's Feet Lines

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_ONLY

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Botulinum Toxin Type A

Subjects who receive botulinum toxin Type A injected into crow's feet line areas per clinical practice.

Botulinum Toxin Type A

Intervention Type BIOLOGICAL

Botulinum toxin Type A injected into crow's feet line areas per clinical practice.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Botulinum Toxin Type A

Botulinum toxin Type A injected into crow's feet line areas per clinical practice.

Intervention Type BIOLOGICAL

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

BOTOX® onabotulinumtoxinA

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Subject and Investigator decision to treat crow's feet lines with Botox®

Exclusion Criteria

* None
Minimum Eligible Age

18 Years

Maximum Eligible Age

75 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Allergan

INDUSTRY

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Medical Director

Role: STUDY_DIRECTOR

Allergan

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Dr. Robbin Clinic

Gangnam-gu, Seoul, South Korea

Site Status

Countries

Review the countries where the study has at least one active or historical site.

South Korea

Related Links

Access external resources that provide additional context or updates about the study.

http://www.allerganclinicaltrials.com

More Information

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

191622-147

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

BOTOX® in the Treatment of Upper Facial Lines in Japan
NCT01797094 COMPLETED PHASE3
Efficacy and Safety Assessment of Botulax® and BOTOX® for Improvement of Glabellar Lines.
NCT05380154 COMPLETED PHASE3
Safety and Efficacy of Two Types of Botulinum Toxin Type A For the Treatment of Glabellar Lines
NCT01271452 COMPLETED PHASE4
A Study to Assess the Adverse Events and Effectiveness of BOTOX Injections for the Treatment of Moderate to Severe Forehead Lines in Chinese Adult Participants
NCT06174688 COMPLETED PHASE3
A Safety and Efficacy Study of OnabotulinumtoxinA in Upper Facial Rhytides
NCT02261493 COMPLETED PHASE3
A Study to Evaluate Sequential Administration of AGN-151586 and OnabotulinumtoxinA (BOTOX) Injections in Adult Participants for Treatment of Glabellar Lines
NCT05496335 COMPLETED PHASE1
Efficacy and Safety of Botulinum Toxin at Moderate to Severe Glabellar Lines
NCT04830345 COMPLETED PHASE3
A Study to Assess Adverse Events and Change in Disease Activity of Intramuscular AGN-151586 Injection in Toxin-Naïve Adult Participants With Glabellar Lines
NCT05248880 COMPLETED PHASE3
Split-Face Study Comparing Botox and Jeuveau in Treating Glabellar Lines
NCT04715048 ACTIVE_NOT_RECRUITING EARLY_PHASE1
A Study to Evaluate Participant Satisfaction and Natural Outcomes Following Administration of BOTOX Cosmetic Injections in Adult Participants for Treatment of Upper Facial Lines
NCT06218251 COMPLETED PHASE4
Botulinum Type A Toxin in the Treatment of Lateral Canthal Lines (Crow's Feet)
NCT00247559 COMPLETED PHASE2
Efficacy and Safety of Botulinum Toxin Type A Haemagglutinin Complex Next Generation (BTX-A-HAC NG) in Glabellar Lines
NCT02493946 COMPLETED PHASE3
A Study of Subject Satisfaction With BOTOX® Cosmetic Treatment in Facial Rhytides
NCT01777620 COMPLETED PHASE4
The Safety and Efficacy Study of PROTOXIN in Subjects With Moderate to Severe Glabellar Lines
NCT04996810 COMPLETED PHASE1/PHASE2
Safety and Efficacy of CKDB-501B in Subjects With Moderate-to-severe Glabellar Lines
NCT05428930 COMPLETED PHASE1
Long-Term Patient Satisfaction of Facial Aesthetic Treatment With BOTOX®
NCT01608672 COMPLETED
Efficacy and Safety of Clostridium Botulinum Toxin Type A to Improve Appearance of Moderate to Severe Glabellar Lines
NCT02353871 COMPLETED PHASE3
Efficacy and Safety of Botulinum Toxin Type A for Injection to Treat Glabellar Lines
NCT02303002 COMPLETED PHASE2
Safety and Efficacy Study of Botulinum Toxin Type A to Treat Glabellar Lines
NCT01485601 COMPLETED PHASE2
A Safety and Efficacy Study of OnabotulinumtoxinA in Forehead and Glabellar Facial Rhytides
NCT02261467 COMPLETED PHASE3
A Study to Assess Adverse Events and Change in Disease Activity of Intramuscular AGN-151586 Injection in Adult Participants With Glabellar Lines
NCT05248867 COMPLETED PHASE3
Intradermal (ID) BOTOX in the Treatment of Facial Fine Lines
NCT04631588 COMPLETED PHASE1
Safety and Efficacy Study of Botulinum Toxin Type A for the Treatment of Forehead and Frown Lines
NCT01391299 COMPLETED NA
A Study of OnabotulinumtoxinA X Injection in Adult Participants With Glabellar Lines
NCT05013424 COMPLETED PHASE2
MEDITOXIN® in Treatment of Crow's Feet Line
NCT03317574 COMPLETED PHASE3